From the origin of NASH to the future of metabolic fatty liver diseaseAndreas Geier, Dina Tiniakos, Helmut Denk, Michael Trauner
25 February 2021
Niche-specific functional heterogeneity of intestinal resident macrophagesMaria Francesca Viola, Guy Boeckxstaens
31 December 2020
Gut microbiota-derived metabolites as central regulators in metabolic disordersAllison Agus, Karine Clément, Harry Sokol
3 December 2020
Targeting G protein-coupled receptors for the treatment of chronic pain in the digestive systemLena Gottesman-Katz, Rocco Latorre, Stephen Vanner, Brian L Schmidt, Nigel W Bunnett
3 December 2020
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseasesXiaolin Wang, Yong He, Bryan Mackowiak, Bin Gao
30 October 2020
Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut healthMarina Fassarella, Ellen E Blaak, John Penders, Arjen Nauta, Hauke Smidt, Erwin G Zoetendal
13 October 2020
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological linksHo-Su Lee, Evy Lobbestael, Séverine Vermeire, João Sabino, Isabelle Cleynen
16 October 2020
Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitisSavio George Barreto, Aida Habtezion, Anna Gukovskaya, Aurelia Lugea, Christie Jeon, Dhiraj Yadav, Peter Hegyi, Viktória Venglovecz, Robert Sutton, Stephen J Pandol
24 September 2020
Mucus barrier, mucins and gut microbiota: the expected slimy partners?Paola Paone, Patrice D Cani
11 September 2020
Liquid biopsy in the clinical management of hepatocellular carcinomaJohann von Felden, Teresa Garcia-Lezana, Kornelius Schulze, Bojan Losic, Augusto Villanueva
3 September 2020